Publication: Reversible posterior leukoencephalopathy induced by cancer chemotherapy
dc.contributor.buuauthor | Baytan, Birol | |
dc.contributor.buuauthor | Özdemir, Özlem | |
dc.contributor.buuauthor | Demirkaya, Metin | |
dc.contributor.buuauthor | Evim, Melike Sezgin | |
dc.contributor.buuauthor | Güneş, Adalet Meral | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı | |
dc.contributor.researcherid | AAH-1452-2021 | |
dc.contributor.scopusid | 6506622162 | |
dc.contributor.scopusid | 26647804400 | |
dc.contributor.scopusid | 24331130000 | |
dc.contributor.scopusid | 36337796600 | |
dc.contributor.scopusid | 24072843300 | |
dc.date.accessioned | 2021-12-16T10:33:08Z | |
dc.date.available | 2021-12-16T10:33:08Z | |
dc.date.issued | 2010-09 | |
dc.description.abstract | Reversible posterior leukoencephalopathy, defined by both clinical and neuroimaging findings, can affect children receiving chemotherapy. The syndrome is characterized by hypertension, alterations in mental status, seizures, hallucinations, and acute visual changes and is associated with abnormalities seen in magnetic resonance imaging of symmetric white matter lesions, especially in the parietal and occipital lobes. The etiology of reversible posterior leukoencephalopathy is as yet unknown. Presented here are four cases of reversible posterior leukoencephalopathy induced by chemotherapy, with a brief review of the literature and consideration of possible mechanisms. A diagnosis of reversible posterior leukoencephalopathy should be considered when patients receiving cancer chemotherapy suddenly develop hypertension followed by neurologic complications, especially if presenting with seizures. | |
dc.identifier.citation | Baytan, B. vd. (2010). "Reversible posterior leukoencephalopathy induced by cancer chemotherapy". Pediatric Neurology, 43(3), 197-201. | |
dc.identifier.endpage | 201 | |
dc.identifier.issn | 0887-8994 | |
dc.identifier.issue | 3 | |
dc.identifier.pubmed | 20691942 | |
dc.identifier.scopus | 2-s2.0-77955542463 | |
dc.identifier.startpage | 197 | |
dc.identifier.uri | https://doi.org/10.1016/j.pediatrneurol.2010.05.005 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0887899410002067 | |
dc.identifier.uri | http://hdl.handle.net/11452/23324 | |
dc.identifier.volume | 43 | |
dc.identifier.wos | 000281131400009 | |
dc.indexed.wos | SCIE | |
dc.language.iso | en | |
dc.publisher | Elsevier Science | |
dc.relation.journal | Pediatric Neurology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Acute lymphoplastic-leukemia | |
dc.subject | Encephalopathy syndrome | |
dc.subject | Cortical blindness | |
dc.subject | Children | |
dc.subject | Therapy | |
dc.subject | Neurosciences & neurology | |
dc.subject | Pediatrics | |
dc.subject.emtree | Asparaginase macrogol | |
dc.subject.emtree | Cytarabine | |
dc.subject.emtree | Dexamethasone | |
dc.subject.emtree | Methotrexate | |
dc.subject.emtree | Prednisone | |
dc.subject.emtree | Vincristine | |
dc.subject.emtree | Acute lymphoblastic leukemia | |
dc.subject.emtree | Adolescent | |
dc.subject.emtree | Article | |
dc.subject.emtree | Cancer chemotherapy | |
dc.subject.emtree | Case report | |
dc.subject.emtree | Child | |
dc.subject.emtree | Female | |
dc.subject.emtree | Hallucination | |
dc.subject.emtree | Human | |
dc.subject.emtree | Hypertension | |
dc.subject.emtree | Male | |
dc.subject.emtree | Mental health | |
dc.subject.emtree | Neuroimaging | |
dc.subject.emtree | Neurologic disease | |
dc.subject.emtree | Nuclear magnetic resonance imaging | |
dc.subject.emtree | Occipital lobe | |
dc.subject.emtree | Parietal lobe | |
dc.subject.emtree | Posterior reversible encephalopathy syndrome | |
dc.subject.emtree | Priority journal | |
dc.subject.emtree | School child | |
dc.subject.emtree | Seizure | |
dc.subject.emtree | Visual impairment | |
dc.subject.mesh | Adolescent | |
dc.subject.mesh | Antineoplastic agents | |
dc.subject.mesh | Child | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Leukoencephalopathies | |
dc.subject.mesh | Magnetic resonance imaging | |
dc.subject.mesh | Male | |
dc.subject.mesh | Neoplasms | |
dc.subject.scopus | Posterior Reversible Encephalopathy Syndrome; Eclampsia; Hypertension Encephalopathy | |
dc.subject.wos | Clinical neurology | |
dc.subject.wos | Pediatrics | |
dc.title | Reversible posterior leukoencephalopathy induced by cancer chemotherapy | |
dc.type | Article | |
dc.wos.quartile | Q3 (Clinical neurology) | |
dc.wos.quartile | Q2 (Pediatrics) | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı | |
local.indexed.at | Scopus | |
local.indexed.at | WOS |
Files
License bundle
1 - 1 of 1
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: